204 | Appendix Authors’ contributions and Research funding Affiliations of the authors: (at the moment of study conduct) Katarina Ochodnicka-Mackovicova (K.O-M): Department of Pathology, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, the Netherlands Lymphoma and Myeloma Center Amsterdam (LYMMCARE), the Netherlands Jeroen E.J. Guikema (J.E.J.G): Department of Pathology, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, the Netherlands Lymphoma and Myeloma Center Amsterdam (LYMMCARE), the Netherlands Carel J.M. van Noesel (C.J.M.v N): Department of Pathology, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, the Netherlands Lymphoma and Myeloma Center Amsterdam (LYMMCARE), the Netherlands Ted E. Bradley (T.E.B): Core Facility Genomics, dept. Clinical Genetics, Amsterdam UMC, the Netherlands Martin Haagmans (M.H.): Core Facility Genomics, dept. Clinical Genetics, Amsterdam UMC, the Netherlands Michal Mokry (M.M): Laboratory of Experimental Cardiology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands Central Diagnostics Laboratory, University Medical Center Utrecht, University Utrecht, Utrecht, the Netherlands Mahnoush Bahjat (M.B): Department of Pathology, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, the Netherlands Lymphoma and Myeloma Center Amsterdam (LYMMCARE), the Netherlands
RkJQdWJsaXNoZXIy MTk4NDMw